Michelle Yanez

Michelle Yanez appears in our data through filings on Inhibitor Therapeutics, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 5 May 2023 and the latest from 4 May 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 4 August 2026, reports a share grant in Inhibitor Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 29 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.